Actio Biosciences Doses First Participant in Phase 1a Trial of ABS-1230 for KCNT1-Related Epilepsy

Actio Biosciences, a clinical-stage biotechnology company leveraging a novel approach to genetics and precision medicine to develop new small molecule th...

September 24, 2025 | Wednesday | News
Remedium Bio and Eli Lilly Enter Multi-Target Gene Therapy Collaboration in Type 2 Diabetes and Obesity

Lifespan Vision Ventures is pleased to announce that its portfolio company, Remedium Bio, Inc. ("Remedium"), has entered into a multi-target research and...

September 24, 2025 | Wednesday | News
Illumina Expands Global CDx Partnerships to Advance KRAS-Targeted Precision Oncology

Illumina Inc. (NASDAQ: ILMN) will partner with multiple global pharmaceutical companies to develop companion diagnostics (CDx) enabled on the T...

September 24, 2025 | Wednesday | News
Rise Therapeutics Expands Oral Dendritic Cell Modulator Program into Sjögren’s Disease Following Positive RA Clinical Data

Supported by recent clinical data from the first-ever clinical study of an oral dendritic cell (DC) modulator in rheumatoid arthritis (RA), Rise Therapeu...

September 24, 2025 | Wednesday | News
Revvity and Profluent Join Forces to Advance AI-Enhanced Base Editing with Pin-point™ Platform

Combination of Revvity’s proprietary Pin-point platform and Profluent’s AI-engineered proteins created to inspire accelerated development o...

September 23, 2025 | Tuesday | News
Yatiri Bio Secures Gates Foundation Grant to Advance Proteomics Interoperability for Global Health

Yatiri Bio Inc.  announced it has received a grant from the Gates Foundation to launch a one-year project, Proteomics Interoperability, aimed at imp...

September 23, 2025 | Tuesday | News
Pfizer Tucks Into $4.9 Billion Metsera Feast — Because Nothing Says Slimming Like Bulking Up

  Proposed acquisition to add four highly differentiated clinical-stage incretin and amylin programs to Pfizer’s pipeline Transaction valu...

September 23, 2025 | Tuesday | News
Sartorius Opens GMP Facility in Illkirch to Boost Cell and Gene Therapy Production

New GMP facility for transfection reagents of French sub-group Sartorius Stedim Biotech in Illkirch Facility equipped to support next-generation techn...

September 19, 2025 | Friday | News
Merck Opens Climate-Neutral Life Science Facility in Blarney to Strengthen Global Biopharma Supply

Merck, a leading science and technology company,  announced the official opening of its new Life Science manufacturing facility in Blarney, Ireland....

September 19, 2025 | Friday | News
Sartorius and IMT Open “Lab Space” in Brazil to Advance Biotechnology Training and Innovation

  Sartorius, a leading international partner of life science research and the biopharmaceutical industry,  announced the opening of its new appl...

September 19, 2025 | Friday | News
Sanofi’s Brivekimig Demonstrates Positive Phase 2a Results in Moderate-to-Severe Hidradenitis Suppurativa

In phase 2a study, brivekimig led to clinically meaningful improvements in primary and key secondary endpoints in biologic-naïve patients compared...

September 18, 2025 | Thursday | News
Celltrion Pharm Signs Strategic Trilateral Agreement with BD to Boost Global Prefilled Syringe CMO Business

-Celltrion Pharm , a South Korean biopharmaceutical firm, said on September 16 that it has inked a strategic trilateral agreement with a multination...

September 17, 2025 | Wednesday | News
Parexel and Paradigm Health Form Strategic Partnership to Transform Clinical Trial Execution with AI-Driven Platform

Parexel, a leading global clinical research organization (CRO), and Paradigm Health, a company rebuilding the clinical research ecosystem, announced a st...

September 16, 2025 | Tuesday | News
Thermo Fisher Scientific Launches Olink® Target 48 Neurodegeneration Panel for Absolute Quantification of Key Biomarkers

Targeted proteomics panel delivers absolute quantification of key and emerging biomarkers in one scalable assay Thermo Fisher Scientific Inc., the world...

September 16, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close